By: Adrelia Allen, Senior Director, Clinical Trial Patient Diversity, Merck Research
Clinical trials are a critical part of the research process for new medicines and...
Better access to healthcare equals better health outcomes. Biogen strives to increase access and address the barriers that patient populations face. Oftentimes, health outcomes...
By: Luther T. Clark, MD
Deputy Chief Patient Officer, Merck
The COVID-19 pandemic has shone a light on longstanding health care disparities and amplified the importance...
By: Luther T. Clark, MD, Deputy Chief Patient Officer, Merck
Barriers to participation of racially and ethnically underrepresented patients in clinical trials include: (1) mistrust,...
